期刊文献+

起搏器更换或升级:经验与指南 被引量:9

Replacement or upgrade of pacemakers: experience and guidelines
原文传递
导出
摘要 目前,单腔起搏器的担保时间为8年,双腔起搏器为6年。在起搏器电池耗竭或患者病情变化,如心功能恶化时,患者将面临更换或升级起搏器的问题。而更换本身就是起搏器感染的独立危险因素,而且更换或升级术中、术后常遇到各种棘手的问题,对经验不足的医师来说是巨大的挑战。
作者 沈法荣 张澍
出处 《中华心律失常学杂志》 2012年第3期166-167,共2页 Chinese Journal of Cardiac Arrhythmias
  • 相关文献

参考文献7

  • 1Authors/Task Force Members,McMurray JJ, Adamopoulos S,et al [DB/OL]. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart FaiLure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J ,2012. [ 2012-06-02 ]. http://eurheartj, oxfordjoumals org/content/early/2012/05/17/eurheartj.
  • 2Oginosawa Y, Abe H, Nakashima Y, The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol,2002,25:1605-1611.
  • 3王欢,华伟,丁立刚,王靖,陈柯萍,张澍.起搏器更换相关并发症的单中心分析[J].中华心律失常学杂志,2012,16(3):172-175. 被引量:2
  • 4Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coil Cardiol, 2006, 48: 590-591.
  • 5戴研,陈柯萍,马坚,王方正,陈若菡,华伟,张澍.58例起搏系统相关感染的临床特征与处理[J].中华心律失常学杂志,2012,16(3):168-171. 被引量:14
  • 6Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation,2010, 121:458-477.
  • 7Margey R, McCann H, Blake G, et al. Contemporary management of and outcomes from cardiac device related infections. Europace, 2010, 12: 64-70.

二级参考文献28

  • 1华伟,王方正,朱丽,张澍,陈柯萍,牛红霞,陈新.117例双心室再同步起搏器植入术并发症分析[J].中华心律失常学杂志,2004,8(4):252-254. 被引量:34
  • 2Zhan C, Baine WB, Sedrakyan A, et al. Cardiac device implantation in the United States from 1997 through 2004:a population-based analysis. J Gen Intern Med .2008,23( Suppl 1 ) :13-19.
  • 3Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coil Cardiol,2006,48:590-591.
  • 4Brinie D, Williams K, Guo A, et al. Reasons for escalating pacemaker implants. Am J Cardiol,2006 ,98 :93-97.
  • 5Margey R, McCann H, Blake G, et al. Contemporary management of and outcomes from cardial device related infections. Europace, 2010,12:64-70.
  • 6Nery PB, Fernandes R, Nair GM, et al. Device-related infection among patients with pacemakers and implantable defibrillators : incidence, risk factors, and consequences. J Cardiovasc Electrophysiol,2010,21:786-790.
  • 7Cengiz M,Okutucu S,Ascioglu S, et al. Permanent pacemaker and implantable cardioverter defibrillator infections:seven years of diagnostic and therapeutic experience of a single center. Clin Cardiol,2010,33:406-411.
  • 8Camus C, Leport C, Raffi F, et al. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker:assessment of wire removal. Clin Infect Dis, 1993,17:46-55.
  • 9Sohail MR,Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis ,2007,45 : 166-173.
  • 10Bracke FA, Meijer A, van Gelder LM, et al. Pacemaker lead complications:when is extraction appropriate and what can we learn form published data? Heart ,2001,85:254-259.

共引文献13

同被引文献41

  • 1冯义柏.心脏起搏器植入技术指南[J].中华心律失常学杂志,1998,2(3):217-224. 被引量:31
  • 2王锦志,马坚,吴海英,张奎俊,余培桢,朱克平,王方正.永久性起搏器更换的原因和处理方法(附685例次分析)[J].心脏起搏与心电生理杂志,1995,9(3):140-141. 被引量:4
  • 3邹彤,王志蕾,佟佳宾,李梅,吴素娟,杨杰孚.心脏起搏器电极脱位原因的初步探讨[J].中国心血管病研究,2007,5(6):411-413. 被引量:50
  • 4沈法荣,王志军,黄抒伟,陈建明,凌锋.心脏再同步治疗起搏器更换时原左心室导线的处理[J].中华心律失常学杂志,2007,11(4):249-251. 被引量:1
  • 5Sohail MR, Uslan DZ, Khan AH, et al. Managementand outcome of permanent pacemaker and implant-able cardioverter - defibrillator infections[J], J AmColl Cardiol,2007,49: 1851 _ 1859.
  • 6Chu VH,Crosslin DR,Friedman JY,et al. Staphylo-coccus aureus bacteremia in patients with prostheticdevices: costs and outcomes [J]. Am J Med, 2005,118:el9-e24.
  • 7De Sisti A. Marquez M F. TonetJ. Bonny A. Frank R. Hidden-Lucet F. Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure[J]. Pacing Clin Electrophysiol , 2012.35: 1035-1043.
  • 8ClelandJ G. DaubertJ C. Erdmann E. Freemantle N. Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure[J]. N Engl] Med, 2005,352: 1539-1549.
  • 9Moss A 1, Hall W 1, Cannom D S, Klein H, Brown M W, Daubert 1 P, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events[J]. N Engl1 Med, 2009,361: 1329-1338.
  • 10Goldenberg T, Hall W 1, Beck C A, Moss A 1, Barsheshet A, McNitt S, et al. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)[J]. J Am ColI Cardiol, 2011, 58: 729-737.

引证文献9

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部